$SLAB
Silicon Laboratories Inc

2024 Q4 Form 10-Q Financial Statement

#000162828024045047 Filed on November 04, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $166.4M
YoY Change -32.05%
Cost Of Revenue $76.08M
YoY Change -24.74%
Gross Profit $90.31M
YoY Change -37.18%
Gross Profit Margin 54.28%
Selling, General & Admin $36.79M
YoY Change -9.61%
% of Gross Profit 40.74%
Research & Development $83.23M
YoY Change -3.11%
% of Gross Profit 92.16%
Depreciation & Amortization $11.59M
YoY Change -8.05%
% of Gross Profit 12.83%
Operating Expenses $120.0M
YoY Change -5.2%
Operating Profit -$29.71M
YoY Change -273.05%
Interest Expense $3.209M
YoY Change -48.11%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$26.50M
YoY Change -213.48%
Income Tax $2.000M
% Of Pretax Income
Net Earnings -$28.50M
YoY Change -360.17%
Net Earnings / Revenue -17.13%
Basic Earnings Per Share -$0.88
Diluted Earnings Per Share -$0.88
COMMON SHARES
Basic Shares Outstanding 32.45M shares 32.29M shares
Diluted Shares Outstanding 32.31M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $369.7M
YoY Change -26.92%
Cash & Equivalents $303.1M
Short-Term Investments $66.60M
Other Short-Term Assets $56.09M
YoY Change -21.36%
Inventory $139.5M
Prepaid Expenses
Receivables $48.88M
Other Receivables $0.00
Total Short-Term Assets $614.1M
YoY Change -25.19%
LONG-TERM ASSETS
Property, Plant & Equipment $135.3M
YoY Change -11.18%
Goodwill $376.4M
YoY Change 0.0%
Intangibles $41.94M
YoY Change -41.76%
Long-Term Investments
YoY Change
Other Assets $81.46M
YoY Change -16.08%
Total Long-Term Assets $635.1M
YoY Change -8.99%
TOTAL ASSETS
Total Short-Term Assets $614.1M
Total Long-Term Assets $635.1M
Total Assets $1.249B
YoY Change -17.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.65M
YoY Change -18.97%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $118.3M
YoY Change -45.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $49.55M
YoY Change 19.82%
Total Long-Term Liabilities $49.55M
YoY Change 19.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $118.3M
Total Long-Term Liabilities $49.55M
Total Liabilities $167.9M
YoY Change -35.42%
SHAREHOLDERS EQUITY
Retained Earnings $1.026B
YoY Change -18.8%
Common Stock $3.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.081B
YoY Change
Total Liabilities & Shareholders Equity $1.249B
YoY Change -17.75%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$28.50M
YoY Change -360.17%
Depreciation, Depletion And Amortization $11.59M
YoY Change -8.05%
Cash From Operating Activities $31.63M
YoY Change -1524.64%
INVESTING ACTIVITIES
Capital Expenditures $2.208M
YoY Change -61.96%
Acquisitions
YoY Change
Other Investing Activities $32.41M
YoY Change -80.67%
Cash From Investing Activities $30.20M
YoY Change -81.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 423.0K
YoY Change -100.07%
NET CHANGE
Cash From Operating Activities 31.63M
Cash From Investing Activities 30.20M
Cash From Financing Activities 423.0K
Net Change In Cash 62.25M
YoY Change -112.93%
FREE CASH FLOW
Cash From Operating Activities $31.63M
Capital Expenditures $2.208M
Free Cash Flow $29.42M
YoY Change -466.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001038074
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SILICON LABORATORIES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2793174
dei Entity Address Address Line1
EntityAddressAddressLine1
400 West Cesar Chavez
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78701
dei City Area Code
CityAreaCode
512
dei Local Phone Number
LocalPhoneNumber
416-8500
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
SLAB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32448037 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303082000 usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
000-29823
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32343000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32343000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55567000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16973000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1025544000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1192731000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
272000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1025000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1081386000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1208682000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1249242000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1443056000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166395000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203760000 usd
dei Entity Small Business
EntitySmallBusiness
false
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227504000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
66596000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48879000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29295000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
139489000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
194295000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
56090000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75117000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
614136000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
737931000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135317000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145890000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
376389000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41936000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59533000 usd
CY2024Q3 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
81464000 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
123313000 usd
CY2024Q3 us-gaap Assets
Assets
1249242000 usd
CY2023Q4 us-gaap Assets
Assets
1443056000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44648000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
57498000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49551000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70804000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
167856000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31897000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31897000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
695413000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
76082000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
84735000 usd
us-gaap Cost Of Revenue
CostOfRevenue
196172000 usd
us-gaap Cost Of Revenue
CostOfRevenue
278753000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
90313000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
119025000 usd
us-gaap Gross Profit
GrossProfit
221965000 usd
us-gaap Gross Profit
GrossProfit
416660000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
83228000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
79042000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
249787000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
254340000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36793000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109041000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113363000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
120021000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
106808000 usd
us-gaap Operating Expenses
OperatingExpenses
358828000 usd
us-gaap Operating Expenses
OperatingExpenses
367703000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29708000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12217000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-136863000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
48957000 usd
CY2024Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3487000 usd
CY2023Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2938000 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9009000 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
15554000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
278000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1359000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1050000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4611000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-26499000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13796000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-128904000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59900000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2005000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3388000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38283000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23479000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-60000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1150000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10348000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167187000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35271000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31796000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32114000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31789000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32309000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32078000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32114000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32919000 shares
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28504000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10348000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167187000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35271000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
655000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1553000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1526000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
5936000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-11000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-68000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-52000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-4542000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-5000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
409000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
270000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-135000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
195000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
234000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
38000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
661000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1835000 usd
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1614000 usd
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
10305000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
135000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
344000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
317000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2216000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1491000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1297000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8089000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27978000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11839000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-165890000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43360000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28504000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
526000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
422000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15913000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1081386000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1258897000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10348000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1491000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-588000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16168000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5942000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159928000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31789000 shares
slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
1130000 shares
slab Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
32919000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2023Q3 slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
0 shares
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
116600000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
173802000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22889000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20493000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
139489000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
194295000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2200000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2300000 usd
CY2024Q3 slab Maximum Cash And Cash Equivalents Used In Calculating Net Leverage Ratio
MaximumCashAndCashEquivalentsUsedInCalculatingNetLeverageRatio
750000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166395000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203760000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
695413000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
695413000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45358000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37167000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6054000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4446000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
39304000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23500000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.400
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
48100000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6300000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5300000 usd
CY2024Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
1800000 usd
CY2023Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.10
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
4400000 usd
us-gaap Restructuring Charges
RestructuringCharges
900000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
5300000 usd
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
900000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
211720000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
376389000 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
45000000 usd
CY2024Q3 slab Deferred Revenue And Returns Liability Current
DeferredRevenueAndReturnsLiabilityCurrent
8478000 usd
CY2023Q4 slab Deferred Revenue And Returns Liability Current
DeferredRevenueAndReturnsLiabilityCurrent
2117000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
65179000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58955000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
118305000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
163570000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
234374000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27766000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28504000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32309000 shares
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
526000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1093029000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1259922000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1208682000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167187000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1297000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6683000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45277000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1081386000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1405008000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35271000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
8089000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-9112000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
213130000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37360000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-3564000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1259922000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167187000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35271000 usd
us-gaap Depreciation
Depreciation
19302000 usd
us-gaap Depreciation
Depreciation
18992000 usd
slab Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
17596000 usd
slab Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
19162000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
960000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
45358000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37167000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1150000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
29100000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5881000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19585000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30706000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-54724000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66971000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-23091000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8085000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13849000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-37039000 usd
slab Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
-5004000 usd
slab Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
-39155000 usd
slab Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
6361000 usd
slab Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
3286000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-13946000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
6794000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24039000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48885000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
28363000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
91493000 usd
slab Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
44057000 usd
slab Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
365073000 usd
slab Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
131008000 usd
slab Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
171766000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7785000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18533000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
12382000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
395000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
151299000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
426418000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
80000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
45000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
571157000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
217137000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16078000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17239000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9396000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8013000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-51682000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-717520000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
75578000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-339987000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227504000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
499915000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
303082000 usd
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 31. Fiscal 2024 will have 52 weeks and fiscal 2023 had 52 weeks. In a 52-week year, each fiscal quarter consists of 13 weeks.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation, and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. The Company periodically reviews the assumptions used in its financial statement estimates.</span></div>
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28504000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10348000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167187000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35271000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32309000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31796000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32114000 shares
CY2024Q3 slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
0 shares
CY2023Q3 slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
282000 shares
slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
0 shares
CY2024Q3 slab Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
32309000 shares
CY2023Q3 slab Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
32078000 shares
slab Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
32114000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.21
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.21
CY2024Q3 slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
100000 shares
slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
200000 shares
slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
700000 shares
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
211220000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
66596000 usd
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
277816000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
137195000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
211720000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
348915000 usd
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
277467000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
404000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
55000 usd
CY2024Q3 slab Debt Securities Available For Sale And Cash Equivalents Fair Value
DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue
277816000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
211220000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66596000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
350144000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
206000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1435000 usd
CY2023Q4 slab Debt Securities Available For Sale And Cash Equivalents Fair Value
DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue
348915000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
137195000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
211720000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
35789000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
35869000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
30458000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
30727000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
66247000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66596000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
0 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
8211000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
55000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
8211000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
55000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
40704000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
128000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
126882000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1307000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
167586000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1435000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166395000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203760000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15903000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5790000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2252000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
505000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13651000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5285000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
32721000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
110000000.0 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.076
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38300000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.297
CY2024Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3800000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-045047-index-headers.html Edgar Link pending
0001628280-24-045047-index.html Edgar Link pending
0001628280-24-045047.txt Edgar Link pending
0001628280-24-045047-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slab-20240928.htm Edgar Link pending
slab-20240928.xsd Edgar Link pending
slab-20240928xexx311.htm Edgar Link pending
slab-20240928xexx312.htm Edgar Link pending
slab-20240928xexx321.htm Edgar Link pending
slab-20240928_cal.xml Edgar Link unprocessable
slab-20240928_def.xml Edgar Link unprocessable
slab-20240928_lab.xml Edgar Link unprocessable
slab-20240928_pre.xml Edgar Link unprocessable
slab-20240928_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable